This book will be the first that focuses on solely on model organisms for lymphoma. It's editors are internationally recognized in the field.
This book will be the first that focuses on solely on model organisms for lymphoma
The editor Peter J. Quesenberry is internationally recognized in the field
In-depth discussion of lymphoma models and their prognostic factors
Recent developments in the therapy of non-Hodgkin lymphoma have improved response and survival rates in patients with these conditions. This book is focused on the biology, prognostic factors and novel targets of non-Hodgkin lymphoma. We believe that understanding the pathophysiology of non-Hodgkin lymphoma provides a mean to improve its risk-stratification and treatment. This book is intended for medical and healthcare professionals involved in the research and clinical care of patients with non-Hodgkin lymphoma.
Cancer Stem Cells: A Matter of Perspective.- B and T-cell development.- HIV lymphomagenesis.- Epstein-Barr Virus Lymphomagenesis and Therapeutic Targets.- Antigen driven lymphomagenesis.- Pre-clinical lymphoma models.- Prognostic factors in B-cell lymphoma.- Prognostic factors in T-cell lymphoma.- Prognostic factors in HIV-associated lymphoma.- Future directions on the treatment of aggressive non-Hodgkin lymphoma.- New monoclonal antibodies for indolent non-Hodgkin lymphomas.- Current therapies for T-cell lymphoma.- Stem Cell Transplantation for lymphoma.- Autologous stem cell transplantation in non-Hodgkin lymphoma.- The role of Stem Cell Transplantation for HIV-associated lymphoma.- Stem Cell Transplantation for T-cell lymphoma.- Index.